{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:18:00Z","timestamp":1764173880894},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3,1]]},"DOI":"10.1097\/qai.0b013e31827e818a","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T09:06:59Z","timestamp":1354180019000},"page":"363-365","source":"Crossref","is-referenced-by-count":18,"title":["Hormonal Contraceptive Continuation and Switching in South Africa"],"prefix":"10.1097","volume":"62","author":[{"given":"Jennifer A.","family":"Smit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mags E.","family":"Beksinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-17-20210131","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0010-7824(01)00268-2","article-title":"Temporary discontinuation: a compliance issue in injectable users.","volume":"64","author":"Beksinska","year":"2001","journal-title":"Contraception"},{"key":"R4-17-20210131","first-page":"15","article-title":". Compliance and use behaviour, an issue in injectable as well as oral contraceptive use A study of injectable and oral contraceptive users in Johannesburg.","volume":"24","author":"Beksinska","year":"1998","journal-title":"Br J Fam Plann"},{"key":"R5-17-20210131","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2009.02.001","article-title":". Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception.","volume":"80","author":"Beksinska","year":"2009","journal-title":"Contraception"},{"key":"R6-17-20210131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1728-4465.2010.00234.x","article-title":"Contraceptive switching after method-related discontinuation: levels and differentials.","volume":"41","author":"Ali","year":"2010","journal-title":"Stud Fam Plann"},{"key":"R7-17-20210131","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1363\/3701611","article-title":"What differentiates method stoppers from switchers Contraceptive discontinuation and switching among Honduran women.","volume":"37","author":"Barden-OFallon","year":"2011","journal-title":"Int Perspect Sex Reprod Health"},{"key":"R8-17-20210131","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/AOG.0b013e31821188ad","article-title":". Continuation and satisfaction of reversible contraception.","volume":"117","author":"Peipert","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R9-17-20210131","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/AOG.0b013e31820563d3","article-title":". One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives.","volume":"117","author":"Raine","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R10-17-20210131","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1097\/QAD.0b013e32833a2537","article-title":". Hormonal contraception and HIV acquisition: reanalysis using marginal structural modelling.","volume":"24","author":"Morrison","year":"2010","journal-title":"AIDS"},{"key":"R11-17-20210131","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1097\/QAD.0b013e328270388a","article-title":". Hormonal contraceptive use, herpes simplex virus infection, and the risk of HIV-1 acquisition among Kenyan women.","volume":"21","author":"Baeten","year":"2007","journal-title":"AIDS"},{"key":"R12-17-20210131","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1473-3099(11)70247-X","article-title":". Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study.","volume":"12","author":"Heffron","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"R13-17-20210131","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/QAD.0b013e32834fa13d","article-title":". Hormonal contraception and the risk of HIV acquisition among women in South Africa.","volume":"26","author":"Morrison","year":"2012","journal-title":"AIDS"},{"key":"R14-17-20210131","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.contraception.2007.02.002","article-title":". Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort.","volume":"75","author":"Kleinschmidt","year":"2007","journal-title":"Contraception"},{"key":"R18-17-20210131","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.contraception.2008.11.009","article-title":". Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate.","volume":"79","author":"Beksinska","year":"2009","journal-title":"Contraception"},{"key":"R19-17-20210131","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S1473-3099(12)70109-3","article-title":"HIV-1 transmission risks from norethisterone enanthate and depot-medroxyprogesterone acetate should be evaluated separately.","volume":"12","author":"Beksinska","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"R20-17-20210131","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tips.2004.09.005","article-title":". Not all progestins are the same: implications for usage.","volume":"11","author":"Hapgood","year":"2004","journal-title":"Trends Pharmacol Sci"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-201303010-00017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:54:29Z","timestamp":1618037669000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201303010-00017"}},"subtitle":["Implications for Evaluating the Association of Injectable Hormonal Contraceptive Use and HIV"],"short-title":[],"issued":{"date-parts":[[2013,3,1]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31827e818a","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3,1]]}}}